TIM-3 in Prostate Health: A Crucial Factor in the Microbiome-Immune Balance

Area of Science:

• Immunology
• Microbiology
• Urology

Background:

• Prostate diseases like prostatitis, BPH, and cancer involve immune dysregulation influenced by the microbiome.
• The immune checkpoint receptor T cell immunoglobulin and mucin-domain containing-3 (TIM-3) plays a role in immune regulation.

Purpose of the Study:

• To review the role of TIM-3 in the prostate microbiome-immune axis.
• To explore TIM-3's implications in prostate-related diseases.
• To propose therapeutic strategies targeting TIM-3 and the microbiome.

Main Methods:

• Literature review of studies on TIM-3, prostate diseases, and the microbiome.
• Analysis of how microbial metabolites affect TIM-3 expression.
• Exploration of potential therapeutic interventions.

Main Results:

• TIM-3 modulates immune responses in the prostate, affecting Tregs, inflammation, and tolerance.
• Microbial metabolites and components can alter TIM-3 expression, leading to immune imbalance.
• TIM-3 blockade combined with microbiome modulation shows promise for prostate conditions.

Conclusions:

• TIM-3 is a critical factor in the prostate microbiome-immune axis.
• Targeting TIM-3 and the microbiome offers a novel therapeutic approach for prostate diseases.
• A multi-omics framework is proposed for TIM-3-centered diagnostics and therapeutics.